199 Fish-Skin Medical Company Completes Funding Round
Kerecis to Use US$2 Million Investment to Further Develop Its Tissue-Regeneration Technology REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND–(Marketwired – Feb 21, 2014) – Kerecis Limited, the emerging tissue-regeneration company, today announced that it has secured US$2 million in series A3 funding. All existing investors participated in the investment round with the addition of two new investors. The money will be spent to further develop MariGen Omega3, the company’s tissue-regeneration technology. MariGen […]